Description:
Trioday Tablet is a fixed-dose combination antiretroviral medication containing Tenofovir Disoproxil Fumarate, Lamivudine, and Efavirenz. It is used in the treatment of HIV-1 (Human Immunodeficiency Virus) infection as part of antiretroviral therapy (ART). The combination works by inhibiting the replication of the virus in the body, thereby reducing the viral load, improving immune function, and delaying the progression to AIDS (Acquired Immunodeficiency Syndrome).
Composition:
Tenofovir Disoproxil Fumarate
Lamivudine
Efavirenz
Therapeutic Uses:
Management of HIV-1 infection in adults and adolescents
Part of a once-daily, single-tablet regimen for improved treatment adherence
Mechanism of Action:
Each component in Trioday plays a distinct role in inhibiting reverse transcriptase, the enzyme responsible for viral replication.
Tenofovir and Lamivudine are nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs)
Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI)
Together, they block the virus from multiplying and help strengthen the immune system.
Packaging:
Available in tablet form, typically packed in bottles or blister strips. Standard packaging options include 30 tablets per bottle or as per market and regulatory requirements.
Note:
Trioday Tablet should be used under the supervision of a qualified healthcare provider. It is not a cure for HIV but plays a key role in managing the condition when taken regularly as prescribed. Routine monitoring of liver function and viral load is advised during treatment.
Would you like this formatted for a product catalog or export datasheet?
